Evaluation of protective effect of myricetin, a bioflavonoid in dimethyl benzanthracene-induced breast cancer in female Wistar rats

South Asian Journal of Cancer

Volumn 3, Issue 2, 2014, Pages 107-111

  Jayakumar, J K ^a   Nirmala, P ^b   Kumar, B A Praveen ^c   Kumar, Ashok P ^b  

^a SRI DEVARAJ URS MEDICAL COLLEGE   (India)

^b ANNAMALAI UNIVERSITY   (India)

^c Kuppam Jagadguru Jayadeva Murugarajendra Medical College   (India)

Author keywords

7,12 dimethylbenzanthracene; Anti oxidants; breast cancer; dimethyl benzanthracene; myricetin; vincristine

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; MYRICETIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST; BREAST CANCER; CANCER PREVENTION; CELL LYSATE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMOLYSATE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

EID: 84898785714     PISSN: 2278330X     EISSN: 22784306     Source Type: Journal    
DOI: 10.4103/2278-330X.130443     Document Type: Article

References (27)

1. Reddy NS, Nirmala P, Chidambaram N, Kumar PA. Quercetin in dimethyl benzanthracene induced breast cancer in rats. Am J Pharmacol Toxicol 2012;7:68-72.
2. Notani PN. Global variation in cancer incidence and mortality. Curr Sci 2001;81:465-74.
3. Sariego J. Breast cancer in the young patient. Am Surg 2010;76:1397-400.
4. Miyata M, Furukawa M, Takahashi K, Gonzalez FJ, Yamazoe Y. Mechanism of 7,12-Dimethylbenz [a] anthracene-induced immunotoxicity: Role of metabolic activation at the target organ. Jpn J Pharmacol 2001;86:302-9.
5. Yang SK, Dower WV. Metabolic pathways of 7,12-dimethylbenz [a] anthracene in hepatic microsomes. Proc Natl Acad Sci USA 1975;72:2601-5.
6. Garcia-Segura LM, Bojda-Diolez F, Lenoir V, Naftolin F, Kerdelhue B. Estrogen-like effects of the mammary carcinogen 7,12-dimethylbenz (alpha) anthracene upon hypothalamic neuronal membranes. Brain Res Bull 1992;28:625-8.
7. Erdman JW Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, et al. Flavonoids and heart: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June, 2006, Washington, DC. J Nutr 2007;137:718-37S.
8. Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, et al. Daily quercetin supplementation dose dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008;138:1615-21.
9. Filipe P, Haigle J, Silva JN, Freitas J, Fernandes A, Mazière JC, et al. Anti-and pro-oxidant effects of quercetin in copper-induced low density lipoprotein oxidation Quercetin as an effective antioxidant against pro-oxidant effects of urate. Eur J Biochem 2004;271:1991-9.
10. Marozzi FJ Jr, Kocialski AB, Malone MH. Studies on the antihistaminic effects of thymoquinone, thymohydroquinone and quercetin. Arzneimittelforschung 1970;20:1574-7.
11. Janisch KM, Williamson G, Needs P, Plumb GW. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin. Free Radic Res 2004;38:877-84.
12. Wadsworth TL, Koop DR. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 1999; 57: 941-9.
13. Chan MM, Mattiacci JA, Hwang HS, Shah A, Fong D. Synergy between ethanol and grape polyphenols, quercetin and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 2000;60:1539-48.
14. Glass GA, Gershon H, Gershon D. The effect of donor and cell age on several characteristics of rat erythrocytes. Exp Hematol 1983;11:987-95.
15. Masotti L, Casali E, Galeotti T. Lipid peroxidation in tumour cells. Free Radic Biol Med 1988;4:377-86.
16. Ohkawa H, Onishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
17. Kakkar P, Das B, Viswanathan PN. A modified spectophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130-2.
18. Navarro J, Obsrador E, Carretero J, Petschen I, Avino J, Perez P, et al. Changes in glutathione status and the antioxidant system in blood and in cancer cells associated with tumour growth in vivo. Free Radic Biol Med 1999;26:410-8.
19. Das U. A radical approach to cancer. Med Sci Monit 2002;8:RA79-92.
20. Elucheri S, Overley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H, et al. CuZn SOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005;24:367-80.
21. Sun Y. Free radicals antioxidant enzymes and carcinogenesis. Free Radic Biol Med 1990;8:583-99.
22. Oberley LW, Oberley TD. Role of antioxidant enzymes in the cancer phenotype. In: Clerch LB, Massaro D, editors. Oxygen, Gene Expression and Cellular Function. Washington: Marcel Dekker; 1997. p. 279-308.
23. Laxmi A, Subramanian S. Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz (a) anthracene induced mammary carcinoma in experimental rats. Biochimie 2013.
24. Skrajnowska D, Bobrowska-Korczak B, Tokarz A, Bialek S, Jezierska E, Makowska J. Copper and resveratrol attenuates serum catalase, glutathione peroxidase, and element values in rats with DMBA-induced mammary carcinogenesis. Biol Trace Elem Res 2013;156:271-8.
25. de Assis S, Wang M, Jin L, Bouker KB, Hilakivi-Clarke LA. Exposure to excess estradiol or leptin during pregnancy increases mammary cancer risk and prevents parity-induced protective genomic changes in rats. Cancer Prev Res (Phila) 2013;6:1194-211.
26. Nandakumar N, Rengarajan T, Balamurugan A, Balasubramanian M. Modulating effects of hesperidin on key carbohydrate-metabolizing enzymes, lipid profile, and membrane-bound adenosine triphosphatases against 7,12-dimethylbenz (a) anthracene-induced breast carcinogenesis. Hum Exp Toxicol 2013.
27. Yang SH, Suh JH, Lee MG, Kim SH. Pharmacokinetic drug interactions between ondansetron and tamoxifen in female Sprague-Dawley rats with DMBA-induced mammary tumor. Anticancer Res 2013;33:521-8.